Proteomic, biomechanical and functional analyses define neutrophil heterogeneity in systemic lupus erythematosus
File(s)Figure 2_ARD paper.jpg (933.78 KB) Figure 5_ARD paper.jpg (457.82 KB)
Supporting information
Supporting information
Author(s)
Type
Journal Article
Abstract
OBJECTIVES: Low-density granulocytes (LDGs) are a distinct subset of proinflammatory and vasculopathic neutrophils expanded in systemic lupus erythematosus (SLE). Neutrophil trafficking and immune function are intimately linked to cellular biophysical properties. This study used proteomic, biomechanical and functional analyses to further define neutrophil heterogeneity in the context of SLE. METHODS: Proteomic/phosphoproteomic analyses were performed in healthy control (HC) normal density neutrophils (NDNs), SLE NDNs and autologous SLE LDGs. The biophysical properties of these neutrophil subsets were analysed by real-time deformability cytometry and lattice light-sheet microscopy. A two-dimensional endothelial flow system and a three-dimensional microfluidic microvasculature mimetic (MMM) were used to decouple the contributions of cell surface mediators and biophysical properties to neutrophil trafficking, respectively. RESULTS: Proteomic and phosphoproteomic differences were detected between HC and SLE neutrophils and between SLE NDNs and LDGs. Increased abundance of type 1 interferon-regulated proteins and differential phosphorylation of proteins associated with cytoskeletal organisation were identified in SLE LDGs relative to SLE NDNs. The cell surface of SLE LDGs was rougher than in SLE and HC NDNs, suggesting membrane perturbances. While SLE LDGs did not display increased binding to endothelial cells in the two-dimensional assay, they were increasingly retained/trapped in the narrow channels of the lung MMM. CONCLUSIONS: Modulation of the neutrophil proteome and distinct changes in biophysical properties are observed alongside differences in neutrophil trafficking. SLE LDGs may be increasingly retained in microvasculature networks, which has important pathogenic implications in the context of lupus organ damage and small vessel vasculopathy.
Date Issued
2021-01-12
Date Acceptance
2020-08-21
Citation
Annals of the Rheumatic Diseases, 2021, 80 (2), pp.209-218
ISSN
0003-4967
Publisher
BMJ Publishing Group
Start Page
209
End Page
218
Journal / Book Title
Annals of the Rheumatic Diseases
Volume
80
Issue
2
Copyright Statement
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/32988843
PII: annrheumdis-2020-218338
Subjects
cardiovascular diseases
inflammation
lupus erythematosus
systemic
Publication Status
Published
Coverage Spatial
England
Date Publish Online
2020-09-28